|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Shares issued for services provided | |||||
| Amortization of debt discount | |||||
| Change in fair value of derivative liabilities | |||||
| Gain on debt extinguishment | |||||
| Financing cost | |||||
| Initial derivative expense | |||||
| Write-off of note receivable and investments | |||||
| Inventory write-off | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaids & other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accrued interest | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Investment in operating companies | |||||
| Investment in note receivable | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from note payable to shareholder, net | |||||
| Proceeds from convertible notes | |||||
| Repayment of convertible notes | |||||
| Proceeds from sale of common stock | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
| Interest paid | |||||
| Discount on convertible notes payable from derivative liability | |||||
| Settlement of derivative liability | |||||
| Conversion of loans and accrued interest into common stock | |||||
| Income tax paid | |||||
| Supplemental schedule of non-cash investing and financing activities | |||||
| Discount on convertible notes payable from derivative liability | |||||
| Conversion of loans and accrued interest into common stock | |||||
Loading...